Cutaneous graft-versus-host disease (GVHD) can be a long-term complication of stem cell transplantation that requires careful management. Speaking from the…
Browsing: Acute Lymphoblastic Leukemia
The European Cancer Patient Coalition (ECPC) is a large European cancer patients organization, comprising hundreds of patient groups from many…
Specialist organizations, such as the European Group for Blood and Marrow Transplantation (EBMT), can provide a range of useful tools…
The European Group for Blood and Marrow Transplantation Nurses Group (EBMT NG) is committed to improving medical education worldwide, to…
The European Group for Blood and Marrow Transplantation Nurses Group (EBMT NG) is a rich resource for nurses and allied…
The European Group for Blood and Marrow Transplantation (EBMT) held its 44th Annual Meeting in 2018, with delegates once again…
Veno-occlusive disease (VOD) is a serious complication that can occur following stem cell transplantation, for which the appropriate management is…
The European Group for Blood and Marrow Transplantation Nurses Group (EBMT NG), founded in 1985, is a well-established coalition that…
The European Group for Blood and Marrow Transplantation (EBMT) is committed to developing and advancing the care of patients. In…
Michael B. Atkins, MD Deputy Director Professor, Oncology & Medicine Georgetown Lombardi Comprehensive Cancer Center discusses the efficacy of axitinib…
In this video, Dr. Brian G.M. Durie explains that second transplant and certain novel therapies may work well for early…
In this weeks video, Brian G.M. Durie explains that even though Revlimid and Pomalyst may reduce white blood cell counts,…
In this weeks video, Dr. Brian G.M. Durie explains that supplements might have side effects or might interfere with medications…
Dr. Karen Reckamp, MD, MS, Co-Director of the Lung Cancer and Thoracic Oncology Program, Medical Director – Clinical Research Operations,…
Dr. Karen Reckamp, MD, MS, Co-Director of the Lung Cancer and Thoracic Oncology Program, Medical Director – Clinical Research Operations,…
Dr. Luis Raez, MD FACP FCCP, Chief of Hematology/Oncology and Medical Director at Memorial Cancer Institute, and Clinical Associate Professor…
Dr. Luis Raez, MD FACP FCCP, Chief of Hematology/Oncology and Medical Director at Memorial Cancer Institute, and Clinical Associate Professor…
We are pleased to have Nathan Pennell, MD, PhD, Director of Lung Cancer Medical Oncology at the Cleveland Clinic Taussig…
We are pleased to have Nathan Pennell, MD, PhD, Director of Lung Cancer Medical Oncology at the Cleveland Clinic Taussig…
We are pleased to have Nathan Pennell, MD, PhD, Director of Lung Cancer Medical Oncology at the Cleveland Clinic Taussig…
Dr. Nate Pennell, Director of Lung Cancer Medical Oncology at Cleveland Clinic Taussig Cancer Center shares 2017 updates for our…
http://cancerGRACE.org/
http://cancerGRACE.org/
http://cancerGRACE.org/
http://cancerGRACE.org/
Dr. Jack West offers discussions for 2017 regarding the changing standard of care for stage 3 non-small cell lung cancer…
Lung Cancer Video Library http://cancerGRACE.org/
Lung Cancer Video Library http://cancerGRACE.org/
Lung Cancer Video Library http://cancerGRACE.org/
Lung Cancer Video Library http://cancerGRACE.org/
Dr. West discusses exciting new advances in NSCLC – PDL1 as a Biomarker for First Line.
Lung Cancer Video Library http://cancerGRACE.org/
Lung Cancer Video Library http://cancerGRACE.org/
Lung Cancer Video Library http://cancerGRACE.org/
Lung Cancer Video Library http://cancerGRACE.org/
Lung Cancer Video Library http://cancerGRACE.org/
Lung Cancer Video Library. http://cancerGRACE.org/
Lung Cancer Video Library http://cancerGRACE.org/
Dr. Jared Weiss, UNC Lineberger Comprehensive Cancer Center, discusses the demographics and epidemiology of lung cancer.
Dr. Jared Weiss, UNC Lineberger Comprehensive Cancer Center, discusses the demographics and epidemiology of lung cancer.
Presented by Dr. Luis E. Raez, MD, FACP, FCCP Chief of Hematology/Oncology and Medical Director of Memorial Cancer Institute (Miami,…
Presented by Dr. Luis E. Raez, MD, FACP, FCCP Chief of Hematology/Oncology and Medical Director of Memorial Cancer Institute (Miami,…
Presented by Dr. Luis E. Raez, MD, FACP, FCCP Chief of Hematology/Oncology and Medical Director of Memorial Cancer Institute (Miami,…
Presented by Dr. Luis E. Raez, MD, FACP, FCCP Chief of Hematology/Oncology and Medical Director of Memorial Cancer Institute (Miami,…
Presented by Dr. Luis E. Raez, MD, FACP, FCCP Chief of Hematology/Oncology and Medical Director of Memorial Cancer Institute (Miami,…
Presented by Dr. Luis E. Raez, MD, FACP, FCCP Chief of Hematology/Oncology and Medical Director of Memorial Cancer Institute (Miami,…
Presented by Dr. Luis E. Raez, MD, FACP, FCCP Chief of Hematology/Oncology and Medical Director of Memorial Cancer Institute (Miami,…
Andrew Chi, MD, PhD at NYU Langone Medical Center Explains How they Will Work with Distant Patients to Get Them…
Andrew Chi, MD, PhD at NYU Langone Medical Center Explains How NYU is 1st Actively Enrolling Site for ONC201 in…
Andrew Chi, MD, PhD at NYU Langone Medical Center Explains How Patients Must Have H3 K27M Tumor Mutation for Clinical…